The Neurointervention Center

Filter Your Results




Results Published From Halted CONSCIOUS-3 Trial of Clazosentan Use in aSAH Patients Undergoing Endovascular Coiling

May 25, 2012—In Stroke, R. Loch Macdonald, MD, et al published findings from the randomized CONSCIOUS-3 trial of clazosentan (Actelion Pharmaceuticals US, Inc., South S…

Stryker's TREVO 2 Data Presented at European Stroke Conference

May 24, 2012—Stryker (Kalamazoo, MI) announced that Raul G. Nogueira, MD, presented the results of the TREVO 2 clinical trial at the European Stroke…

IMS III Trial Enrollment Halted Due to Futility

May 2, 2012—The National Institute of Neurological Disorders and Stroke (NINDS) announced that the Interventional Management of Stroke III (IMS III) trial has stopped enroll…

The Neurointerventional Suite as an Acute Stroke Intervention Unit

Charles M. Strother, MD

April 2012—A streamlined plan to evaluate and treat acute ischemic stroke may improve outcomes and save lives.

Covidien’s Solitaire FR Receives FDA Clearance

March 5, 2012—Covidien (Mansfield, MA) announced that the US Food and Drug Administration has granted 510(k) clearance for the company’s Solitaire FR revascularization dev…

Covidien’s Solitaire FR Device Studied for Clot Retrieval in Stroke Patients

February 3, 2012—The American Stroke Association (ASA) announced data from the SWIFT study, which compared outcomes of treatment with the Solitaire flow restoration (FR) dev…

IMS III Stroke Trial to Include Covidien’s Solitaire FR Device

January 30, 2012—Covidien (Mansfield, MA) announced that the Solitaire FR revascularization device has been approved for investigational use in the Interventional Management…

Penumbra Launches Separator 3D Cerebral Thrombectomy Device in Europe

January 23, 2012—Penumbra, Inc. (Alameda, CA) announced the European launch of Separator 3D, the company’s next-generation clot engagement device for treating cerebral occ…



2017 Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.